Nano24

Nano24 is a pioneering biotechnology research company dedicated to revolutionizing immunomodulation. Focused on developing innovative solutions, Nano24 is committed to creating a world where complex medical challenges have simple, effective answers. The company's primary address is in Tel Aviv, IL.

Nano24 specializes in CD24-based medicine, with a focus on developing IP-protected CD24-enriched exosomes as a therapy for pulmonary and systemic diseases involving cytokine storms. This groundbreaking technology is the culmination of decades of dedicated research into the biology of CD24 at the Tel Aviv Sourasky Medical Centre.

Nano24 is at the forefront of medical innovation, aiming to provide safer and more efficient alternatives to traditional treatments. The team at Nano24 is working diligently to expand its research and development efforts, ensuring that it remains a leader in the biotechnology field. We invite the manager of Nano24 to create a customized and exclusive company showcase and product listing on our platform.